Literature DB >> 8688364

Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment.

W H Kwan1, P M Teo, L T Chow, P H Choi, P J Johnson.   

Abstract

Nasopharyngeal carcinoma (NPC) is a highly chemo- and radiosensitive tumour, distinctive from other head and neck squamous cell carcinomas. Distant metastatic rates correlate directly with T and N stages. The prognosis of metastatic NPC is grave and long term survivors are anecdotal. We encountered an 18-year-old man with locoregionally advanced NPC, who was initially treated with neoadjuvant chemotherapy and radiotherapy, but subsequently relapsed 6 months later in the superior mediastinal and right hilar nodal regions. Further chemotherapy and consolidation radiotherapy resulted in complete remission. He is currently alive and free of disease 5 years and 6 months after the completion of salvage treatment. We recommend aggressive treatment of NPC with isolated intrathoracic nodal relapse and imaging of the mediastinum for non-metastatic Ho's Stage N3 NPC patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8688364     DOI: 10.1016/s0936-6555(05)80041-x

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

1.  Systemic chemotherapy followed by locoregional definitive intensity-modulated radiation therapy yields prolonged survival in nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis.

Authors:  Shao-xuan Hu; Xiao-hui He; Mei Dong; Bo Jia; Sheng-yu Zhou; Jian-liang Yang; Sheng Yang; Chang-Gong Zhang; Peng Liu; Yan Qin; Lin Gui
Journal:  Med Oncol       Date:  2015-07-29       Impact factor: 3.064

2.  Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?

Authors:  Xun Cao; Li-Ru He; Fang-Yun Xie; You-Fang Chen; Zhe-Sheng Wen
Journal:  BMC Cancer       Date:  2011-08-24       Impact factor: 4.430

3.  Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosis.

Authors:  Xun Cao; Rong-Zhen Luo; Li-Ru He; Yong Li; Wen-Qian Lin; You-Fang Chen; Zhe-Sheng Wen
Journal:  Radiat Oncol       Date:  2011-08-26       Impact factor: 3.481

4.  Investigation of the Definition of De Novo Oligometastatic Nasopharyngeal Carcinoma: A Retrospective Study.

Authors:  Hongmei Wang; Fang He; Xuejun Wang; Haoyun Tao; Zhihao Huang; Yawei Yuan; Weijun Zhang
Journal:  J Oncol       Date:  2021-09-15       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.